The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at the agency.
WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines the Trump administration deems as ... [1927 chars]